Infectious Diseases (all articles) | Page 216 of 298 | Links Medicus Content Curation & Alerts in Medicine

Coagulation Abnormalities and Thrombosis in Patients with COVID-19

12 May, 2020 | 03:16h | UTC

Coagulation abnormalities and thrombosis in patients with COVID-19 – The Lancet

Related Commentary on Twitter

Good to see these welcome recommendations today for diagnosis of clotting and its prevention in patients with severe #COVID19 @TheLancetHaem https://t.co/RrtXSIu2Ne by @MarcelLevi @JerroldLevy and colleagues pic.twitter.com/dU17RIj1f2

— Eric Topol (@EricTopol) May 11, 2020

COVID-19 and Postinfection Immunity: Limited Evidence, Many Remaining Questions

12 May, 2020 | 03:21h | UTC

COVID-19 and Postinfection Immunity: Limited Evidence, Many Remaining Questions – JAMA

Related: What policy makers need to know about COVID-19 protective immunity – The Lancet (commentaries on the subject)

Perspective: Which COVID-19 Antivirals Actually Work?

12 May, 2020 | 03:18h | UTC

Perspective: Which COVID-19 Antivirals Actually Work? – Forbes

Triple Therapy Antiviral Combination Seems Promising for COVID-19 in Open-label, Randomized, Phase 2 Trial

11 May, 2020 | 00:42h | UTC

Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial – The Lancet

Commentaries: Interferon beta-1b for COVID-19 – The Lancet AND New triple antiviral drug combination shows early promise for treating COVID-19 in phase 2 randomized trial – The Lancet AND A Drug Cocktail Hastens Recovery in Some Coronavirus Patients – The New York Times AND Triple drug therapy helps coronavirus patients recover more quickly, study finds – CNN AND Triple antiviral drug shows early promise in COVID-19 trial – Reuters AND Expert reaction to a study about a phase 2 trial of a triple antiviral drug combination treatment for COVID-19 – Science Media Centre

Preliminary Study Evaluates Interleukin-1 Blockade for Patients with Severe Covid-19

11 May, 2020 | 00:34h | UTC

Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study – The Lancet Rheumatology

Commentaries: Expert reaction to study looking at use of arthritis drug anakinra in hospitalised patients with severe COVID-19 – Science Media Centre AND Small study of patients with severe COVID-19 treated with the arthritis drug anakinra finds clinical improvements – The Lancet

COVID-19 Research in Brief: 2 May to 8 May, 2020

11 May, 2020 | 00:24h | UTC

COVID-19 Research in Brief: 2 May to 8 May, 2020 – Nature Medicine

Canadian Study Finds Temperature, Latitude Not Associated with COVID-19 Spread

11 May, 2020 | 00:30h | UTC

Impact of climate and public health interventions on the COVID-19 pandemic: A prospective cohort study – Canadian Medical Association Journal

News Release: Canadian study finds temperature, latitude not associated with COVID-19 spread – Canadian Medical Association Journal

The Emerging Long-term Complications of Covid-19, Explained

11 May, 2020 | 00:27h | UTC

The emerging long-term complications of Covid-19, explained – Vox

Position Paper: Antimicrobial Therapeutic Drug Monitoring in Critically Ill Adult Patients

11 May, 2020 | 00:19h | UTC

Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper – Intensive Care Medicine

Commentary: New antibiotic guidelines could save more lives in intensive care units – News Medical

Large Observational Study Finds Hydroxychloroquine Provides no Benefit in Hospitalized Patients with Covid-19

8 May, 2020 | 10:41h | UTC

Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19 – New England Journal of Medicine

Editorial: The Urgency of Care during the Covid-19 Pandemic — Learning as We Go

Treatment of Community-Acquired Pneumonia During the COVID-19 Pandemic

8 May, 2020 | 10:35h | UTC

Treatment of Community-Acquired Pneumonia During the Coronavirus Disease 2019 (COVID-19) Pandemic – Annals of Internal Medicine

Podcast: Studying Potential Covid-19 Therapies

8 May, 2020 | 10:38h | UTC

Audio Interview: Studying Potential Covid-19 Therapies – New England Journal of Medicine

Modeling Shield Immunity to Reduce COVID-19 Epidemic Spread

8 May, 2020 | 10:30h | UTC

Modeling shield immunity to reduce COVID-19 epidemic spread – Nature Medicine

Commentaries: Immunity of Recovered COVID-19 Patients Could Cut Risk of Expanding Economic Activity – Georgia Institute of Technology AND After Recovery From the Coronavirus, Most People Carry Antibodies – New York Times

RCEM Position Statement COVID-19: Resetting Emergency Department Care

8 May, 2020 | 10:32h | UTC

RCEM Position Statement COVID-19: Resetting Emergency Department Care – The Royal College of Emergency Medicine

Commentary: Emergency departments must not return to pre-covid days of overcrowding and lack of safety, says college – The BMJ

[Preprint] Risk Factors for COVID-19 Death in 17 Million Adult NHS Patients

8 May, 2020 | 10:28h | UTC

OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients – medRxiv

Press release: Risk factors for COVID-19 death revealed in world’s largest analysis of patient records to date

Commentary: Risk factors for COVID-19 death revealed in world’s largest analysis of patient records to date – London School of Hygiene & Tropical Medicine

[Preprint] Repeated Seroprevalence of Anti-SARS-CoV-2 IgG Antibodies in a Population-based Sample from Geneva, Switzerland

8 May, 2020 | 10:26h | UTC

Repeated seroprevalence of anti-SARS-CoV-2 IgG antibodies in a population-based sample from Geneva, Switzerland – medRxiv

Related Commentary on Twitter

https://twitter.com/AdamJKucharski/status/1258351580300095488

COVID-19 in Older People: A Rapid Clinical Review

8 May, 2020 | 10:22h | UTC

COVID-19 in Older People: A Rapid Clinical Review – Age and Ageing

New IDSA Statement Raises Concerns Over Sepsis Bundle of Care that May Lead to Excess Use of Antibiotics

8 May, 2020 | 10:04h | UTC

New IDSA Statement Raises Concerns, Offers Recommendations to Improve National Quality Measure for Sepsis Care – Infectious Diseases Society of America

News Release: New IDSA Statement Raises Concerns, Offers Recommendations to Improve National Quality Measure for Sepsis Care

IDSA Guidelines on the Diagnosis of COVID-19

7 May, 2020 | 09:33h | UTC

Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19

Related IDSA Coronavirus Guidelines: Part 1: Treatment and Management AND Part 2: Infection Prevention

IDSA Recommendations: Molecular Testing for Acute Respiratory Tract Infections

7 May, 2020 | 09:32h | UTC

Molecular testing for acute respiratory tract infections: clinical and diagnostic recommendations from the IDSA’s Diagnostics Committee – Clinical Infectious Diseases

Interpreting Diagnostic Tests for SARS-CoV-2

7 May, 2020 | 09:28h | UTC

Interpreting Diagnostic Tests for SARS-CoV-2 – JAMA

AGS Position Statement: Resource Allocation Strategies and Age‐Related Considerations in the COVID‐19 Era

7 May, 2020 | 09:24h | UTC

AGS Position Statement: Resource Allocation Strategies and Age‐Related Considerations in the COVID‐19 Era and Beyond – Journal of the American Geriatrics Society

News Release: Position statement addresses difficult issue: allocating scare resources in COVID-19 era – American Geriatrics Society

“Age should never be used as a means for categorically excluding someone from what is ordinarily the standard of care, nor should age “cut-offs” be used in allocation strategies.”